Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Cheng Peng is a pioneering urologic surgeon whose work bridges complex oncologic surgery and robotic innovation. His primary research focuses on the surgical management of advanced renal cell carcinoma with inferior vena cava (IVC) tumor thrombus, a condition historically requiring highly invasive open procedures with significant morbidity. Dr. Peng’s landmark contributions include the development and validation of a modified sequential vascular control strategy for robot-assisted level III–IV IVC thrombectomy, which mimics the open “milking” technique. This innovation, detailed in his highly cited 2020 paper (23 citations), allows for early release of the first porta hepatis and reduces reliance on cardiopulmonary bypass. His multi-institutional analysis on decision-making for robot-assisted cavectomy versus thrombectomy for level II IVC thrombus (54 citations) provides a critical, evidence-based framework for surgeons. Additionally, his comprehensive case series on paraganglioma of the urinary bladder (38 citations) remains a key reference for this rare tumor. With over 120 total citations, Dr. Peng’s work has directly advanced the frontiers of minimally invasive urologic oncology, offering patients safer, less morbid alternatives to traditional open surgery.